Major review reveals trade-offs in diabetes drugs that could reshape treatment

A comprehensive analysis of diabetes medications shows that while many drugs lower blood sugar effectively, they carry different risks and benefits that doctors and patients often overlook. The findings could force insurers and healthcare systems to reconsider which treatments they prioritize and how they price these widely-used medications.

Originaltitel: Benefits and harms of drug treatment for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials